January 19, 2013

Jan 18, 2013
1,349 views

FDA Advisory Committee Recommends Approval of First in Class SGLT-2(Canagliflozin).

Next Once Weekly GLP-1 (albiglutide) Submitted to FDA for Approval.

Looking for 10,000 seniors to participate in a free program to prevent diabetes (See Item #2).